In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogue
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 153 (1) , 81-86
- https://doi.org/10.1016/s0006-291x(88)81192-6
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Somatostatin in the central nervous system: Physiology and pathological modificationsPublished by Elsevier ,2003
- Somatostatin.BMJ, 1987
- Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin AnalogueNew England Journal of Medicine, 1987
- Pharmacological studies of somatostatin and somatostatin-analogues: Therapeutic advances and perspectivesLife Sciences, 1987
- Therapeutic efficacy of a somatostatin analogue (SMS 201–995) in active acromegalyJournal of Neurosurgery, 1986
- Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1986
- Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue.BMJ, 1986
- A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growthActa Endocrinologica, 1985
- SomatostatinNew England Journal of Medicine, 1983
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973